Related references
Note: Only part of the references are listed.Ets Family Protein, Erg Expression in Developing and Adult Mouse Tissues by a Highly Specific Monoclonal Antibody
Ahmed A. Mohamed et al.
Journal of Cancer (2012)
The Utility of ERG/P63 Double Immunohistochemical Staining in the Diagnosis of Limited Cancer in Prostate Needle Biopsies
Oksana Yaskiv et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Immunohistochemistry for ERG Expression as a Surrogate for TMPRSS2-ERG Fusion Detection in Prostatic Adenocarcinomas
Alcides Chaux et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
The Diagnostic Utility of Novel Immunohistochemical Marker ERG in the Workup of Prostate Biopsies With Atypical Glands Suspicious for Cancer
Huiying He et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
ERG Transcription Factor as an Immunohistochemical Marker for Vascular Endothelial Tumors and Prostatic Carcinoma
Markku Miettinen et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
PTEN genomic deletion is an early event associated with ERG gene rearrangements in prostate cancer
Tarek A. Bismar et al.
BJU INTERNATIONAL (2011)
The Impact of Eliminating Socioeconomic and Racial Disparities on Premature Cancer Deaths
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Gene fusions find an ERG-way to tumor inflammation
Sarah K. Martin et al.
CANCER BIOLOGY & THERAPY (2011)
ERG oncogene modulates prostaglandin signaling in prostate cancer cells
Ahmed A. Mohamed et al.
CANCER BIOLOGY & THERAPY (2011)
Mechanistic Rationale for Inhibition of Poly(ADP-Ribose) Polymerase in ETS Gene Fusion-Positive Prostate Cancer
J. Chad Brenner et al.
CANCER CELL (2011)
Activation of NF-κB by TMPRSS2/ERG Fusion Isoforms through Toll-Like Receptor-4
Jianghua Wang et al.
CANCER RESEARCH (2011)
ERG Status Is Unrelated to PSA Recurrence in Radically Operated Prostate Cancer in the Absence of Antihormonal Therapy
Sarah Minner et al.
CLINICAL CANCER RESEARCH (2011)
Common Gene Rearrangements in Prostate Cancer
Mark A. Rubin et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Single Focus Prostate Cancer: Pathological Features and ERG Fusion Status
Sara M. Falzarano et al.
JOURNAL OF UROLOGY (2011)
Antibody EPR3864 is specific for ERG genomic fusions in prostate cancer: implications for pathological practice
Geert J. L. H. van Leenders et al.
MODERN PATHOLOGY (2011)
ERG gene rearrangements are common in prostatic small cell carcinomas
Tamara L. Lotan et al.
MODERN PATHOLOGY (2011)
TMPRSS2/ERG Promotes Epithelial to Mesenchymal Transition through the ZEB1/ZEB2 Axis in a Prostate Cancer Model
Orit Leshem et al.
PLOS ONE (2011)
ERG gene rearrangement status in prostate cancer detected by immunohistochemistry
Sara Moscovita Falzarano et al.
VIRCHOWS ARCHIV (2011)
Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer
A. H. M. Reid et al.
BRITISH JOURNAL OF CANCER (2010)
An Integrated Network of Androgen Receptor, Polycomb, and TMPRSS2-ERG Gene Fusions in Prostate Cancer Progression
Jindan Yu et al.
CANCER CELL (2010)
1 alpha,25-Dihydroxyvitamin D-3 Inhibits Growth of VCaP Prostate Cancer Cells Despite Inducing the Growth-Promoting TMPRSS2:ERG Gene Fusion
Michele N. Washington et al.
ENDOCRINOLOGY (2010)
ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor
Veit J. Scheble et al.
MODERN PATHOLOGY (2010)
Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements
Michael C. Haffner et al.
NATURE GENETICS (2010)
ETS Transcription Factors Control Transcription of EZH2 and Epigenetic Silencing of the Tumor Suppressor Gene Nkx3.1 in Prostate Cancer
Paolo Kunderfranco et al.
PLOS ONE (2010)
ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification
B. Furusato et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2010)
Antibody-Based Detection of ERG Rearrangement-Positive Prostate Cancer
Kyung Park et al.
NEOPLASIA (2010)
TMPRSS2-ERG Gene Fusion Is Not Associated with Outcome in Patients Treated by Prostatectomy
Anuradha Gopalan et al.
CANCER RESEARCH (2009)
ETS Gene Fusions in Prostate Cancer: From Discovery to Daily Clinical Practice
Scott A. Tomlins et al.
EUROPEAN UROLOGY (2009)
Persistence of expression of the TMPRSS2:ERG fusion gene after pre-surgery androgen ablation may be associated with early prostate specific antigen relapse of prostate cancer: Preliminary results
L. Bonaccorsi et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2009)
Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression
Bo Han et al.
MODERN PATHOLOGY (2009)
Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis
Jennifer C. King et al.
NATURE GENETICS (2009)
Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate
Brett S. Carver et al.
NATURE GENETICS (2009)
ETS gene fusions in prostate cancer
Jeremy P. Clark et al.
NATURE REVIEWS UROLOGY (2009)
The role of the ETS factor erg in zebrafish vasculogenesis
Felix Ellett et al.
MECHANISMS OF DEVELOPMENT (2009)
ETS family transcription factors collaborate with alternative signaling pathways to induce carcinoma from adult murine prostate cells
Yang Zong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
N-myc Downstream Regulated Gene 1 (NDRG1) Is Fused to ERG in Prostate Cancer
Dorothee Pflueger et al.
NEOPLASIA (2009)
Transcription factor Erg regulates angiogenesis and endothelial apoptosis through VE-cadherin
Graeme M. Birdsey et al.
BLOOD (2008)
Fusion in the ETS gene family and prostate cancer
S. A. Narod et al.
BRITISH JOURNAL OF CANCER (2008)
Pleiotropic Biological Activities of Alternatively Spliced TMPRSS2/ERG Fusion Gene Transcripts
Jianghua Wang et al.
CANCER RESEARCH (2008)
Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications
Juan-Miguel Mosquera et al.
CLINICAL CANCER RESEARCH (2008)
TMPRSS2:ERG fusion identifies a subgroup of prostate cancers with a favorable prognosis
Outi R. Saramaki et al.
CLINICAL CANCER RESEARCH (2008)
Delineation of TMPRSS2-ERG splice variants in prostate cancer
Ying Hu et al.
CLINICAL CANCER RESEARCH (2008)
ETS transcription factors: oncogenes and tumor suppressor genes as therapeutic targets for prostate cancer
David P. Turner et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2008)
Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome
Maisa Yoshimoto et al.
MODERN PATHOLOGY (2008)
TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation
C. Sun et al.
ONCOGENE (2008)
A causal role for ERG in neoplastic transformation of prostate epithelium
Olga Klezovitch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Role of the TMPRSS2-ERG gene fusion in prostate cancer
Arul M. Chinnaiyan
NEOPLASIA (2008)
Complex patterns of ETS gene alteration arise during cancer development in the human prostate
J. Clark et al.
ONCOGENE (2008)
Recurrent gene fusions in prostate cancer
Chandan Kumar-Sinha et al.
NATURE REVIEWS CANCER (2008)
Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer
R. K. Nam et al.
BRITISH JOURNAL OF CANCER (2007)
Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancers
Ashish B. Rajput et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer
Scott A. Tomlins et al.
NATURE (2007)
TMPRSS2: ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort
F. Demichelis et al.
ONCOGENE (2007)
TMPRSS2-ERG fusion prostate cancer:: An early molecular event associated with invasion
Sven Perner et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
Integrative molecular concept modeling of prostate cancer progression
Scott A. Tomlins et al.
NATURE GENETICS (2007)
TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer
Karin G. Hermans et al.
CANCER RESEARCH (2006)
TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming
Kristiina Iljin et al.
CANCER RESEARCH (2006)
TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions
Nuno Cerveira et al.
NEOPLASIA (2006)
TMPRSS2:: ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer
Sven Perner et al.
CANCER RESEARCH (2006)
Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer
Jianghua Wang et al.
CANCER RESEARCH (2006)
15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis
Seung-Jae Myung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer
Ido Wolf et al.
CANCER RESEARCH (2006)
Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: Implications for patient care
JI Epstein et al.
JOURNAL OF UROLOGY (2006)
Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype:: A cancer and leukemia group B study
G Marcucci et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
SA Tomlins et al.
SCIENCE (2005)
Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome
G Petrovics et al.
ONCOGENE (2005)
Acute myeloid leukemia with complex karyotypes and abnormal chromosome 21:: Amplification discloses overexpression of APP, ETS2, and ERG genes
CD Baldus et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma -: A gene expression analysis on total and microdissected prostate tissue
T Ernst et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Share Paper
